FIELD: medicine.
SUBSTANCE: invention relates to experimental medicine and can be used to create a model of zero stage of osteonecrosis of the lower jaw of drug addicts when testing various methods of treatment and prevention of osteonecrosis of the jaws caused by artisanal methamphetamine. Method includes daily intragastric introduction in 3-month-old rats of model non-narcotic mixture obtained by reconstituting such medicine as Anarilin using iodine and red phosphorus, at a dose of 70–90 mg/kg for 12 weeks.
EFFECT: invention allows to create model of osteonecrosis of the lower jaw using molecular analogs of impurities, which can be formed during synthesis of methamphetamine in artisanal conditions.
1 cl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MODELING ASEPTIC AMINOBISPHOSPHONATE OSTEONECROSIS OF LOWER JAWS IN LABORATORY WHITE RATS | 2016 |
|
RU2653627C1 |
EXPERIMENTAL MODEL OF TREATING APSEPTIC BISPHOSPHONATE OSTEONECROSIS OF LOWER JAW IN LABORATORY WHITE RATS | 2017 |
|
RU2687744C1 |
METHOD FOR SIMULATING LIVER CIRRHOSIS IN EXPERIMENT | 2023 |
|
RU2817175C1 |
METHOD OF CONSERVATIVE TREATMENT OF BISPHOSPHONATE OSTEONECROSIS OF JAWS | 2017 |
|
RU2691075C1 |
RADIX SALVIAE MILTIORRHIZAE (DAN SHEN) OR PREPARATIONS THEREOF APPLICATION FOR PREPARATION OF DRUGS FOR TREATMENT OF DISEASES RELATED TO LIVER FIBROSIS | 2013 |
|
RU2623147C2 |
METHOD FOR MODELLING OSTEOPOROSIS | 2008 |
|
RU2384894C1 |
METHOD FOR SIMULATING OSTEORESORPTION UNDER OSTEOGENESIS CONDITIONS | 2013 |
|
RU2524128C1 |
MEDICINAL PRODUCT WITH ANTICOAGULANT (INHIBITOR OF FACTOR IIA), ANTITHROMBOTIC, ANTI-INFLAMMATORY ACTIVITIES AND CONTAINING 5,7-DI(THIOPHEN-2-IL)-4,5-DIHYDRO-[1,2,4]TRIAZOLO[1,5-a ]PYRIMIDINE | 2022 |
|
RU2798587C1 |
METHOD FOR SIMULATING ACUTE LIVER DISEASE IN PREGNANT WOMEN | 2015 |
|
RU2610536C1 |
USE OF ENISAMIUM IODIDE FOR THE PREVENTION AND/OR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | 2022 |
|
RU2799328C1 |
Authors
Dates
2019-02-15—Published
2018-02-15—Filed